Synergy CHC Corp. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q1 of fiscal 2026, the quarter ended Mar 31, 2026 was Nutraceuticals at $4.8 million, 88% of the total. By sales mix, the largest line in Q1 of fiscal 2026, the quarter ended Mar 31, 2026 was Retail at $3.7 million, 67% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Mar 31, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
Q1 FY2020
Mar 31, 2020
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
28
|
5
|
6
|
8
|
8
|
8
|
10
|
7
|
6
|
| Operating segments | |||||||||
| Nutraceuticals |
28
-8.8%
share 100.8%
|
5
-27.3%
share 87.8%
|
—
|
—
|
—
|
7
share 81.3%
|
—
|
—
|
—
|
| Beverages |
1
share 4.6%
|
1
+2056.7%
share 12.2%
|
—
|
—
|
—
|
0
share 0.4%
|
—
|
—
|
—
|
| Sales mix | |||||||||
| Retail |
21
-13.1%
share 74.2%
|
4
-31.5%
share 67.5%
|
8
+2.4%
share 129.9%
|
—
|
—
|
5
share 66.2%
|
8
share 74.9%
|
—
|
—
|
| Online |
7
-28.1%
share 25.8%
|
2
-35.3%
share 32.5%
|
1
-57.9%
share 17.9%
|
2
+60.8%
share 27.6%
|
2
share 25.5%
|
3
share 33.8%
|
3
share 25.1%
|
1
share 19.3%
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- SNYRQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Westbrook, ME
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1562733
- Former names
- Synergy Strips Corp. (until Aug 6, 2015); Oro Capital Corporation, Inc. (until Apr 24, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.